Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SoluMatrix Abiraterone Acetate Extension Study
NCT02887976Phase 3Completed
- Sponsor
- GU Research Network
- Start
- Sep 2016
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of abiraterone in prostate cancer (PCa), sponsored by GU Research Network. Started Sep 2016; status: completed.
02
Drugs
abiraterone
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02887976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02887976.